UPDATE 1-Covidien gets FDA nod for brain device

* Device treat brain aneurysms, a bulging of blood vessels

* Device is made by Covidien unit ev3

WASHINGTON, April 6 (Reuters) – U.S. health regulators on
Wednesday approved Covidien Plc’s (COV.N: Quote, Profile, Research) device to treat brain
aneurysms, a bulging of blood vessels that can lead to nerve
damage and even death.

The device, named Pipeline Embolization Device and made by
Covidien’s unit ev3, is a flexible mesh tube that can be used
to block off large aneurysms in a major blood vessel supplying
blood to the front of the brain, the regulator said on its
website.

Ev3 was acquired by Covidien in July last year.

The device can also reduce the likelihood that an aneurysm
will rupture, the U.S. Food and Drug Administration said.

The device is implanted by attaching it to the end of a
catheter, which is inserted into an artery in the leg.

The American Association of Neurological Surgeons estimates
that every year 30,000 people in the United States experience a
ruptured brain aneurysm.

Aneurysms are more prevalent in people ages 50 to 60 and
three times more prevalent in women.
(Reporting by Esha Dey; Editing by Steve Orlofsky)

UPDATE 1-Covidien gets FDA nod for brain device